These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4997122)

  • 21. Synthesis of di- and tripeptides and assay in vivo for activity in the thyrotropin releasing hormone and the luteinizing releasing hormone systems.
    Sievertsson H; Chang JK; Folkers K; Bowers CY
    J Med Chem; 1972 Jan; 15(1):8-11. PubMed ID: 4621372
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis of a series of residue 1 (pyroglutamic acid) analogs of thyrotrophin releasing hormone.
    Bauce LG; Goren HJ
    Int J Pept Protein Res; 1979; 14(3):216-26. PubMed ID: 118133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity-structure relationships of the thyrotropin releasing hormone.
    Bowers CY; Weil A; Chang JK; Sievertsson H; Enzmann F; Folkers K
    Biochem Biophys Res Commun; 1970 Aug; 40(3):683-91. PubMed ID: 4992628
    [No Abstract]   [Full Text] [Related]  

  • 24. The inhibitory action of analogs of thyrotropin-releasing hormone on the release of thyrotropin in vitro.
    Castensson S; Björkman S; Sievertsson H
    Acta Pharm Suec; 1977; 14(5-6):505-16. PubMed ID: 413330
    [No Abstract]   [Full Text] [Related]  

  • 25. Thyrotropin and prolactin inhibitory studies by compounds related to the thyrotropin releasing hormone.
    Sievertsson H; Castensson S; Andersson K; Björkman S; Bowers CY
    Biochem Biophys Res Commun; 1975 Oct; 66(4):1401-7. PubMed ID: 811221
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and conformations of hypothalamic hormone releasing factors: two QRF-analogues containing backbone N-methyl groups.
    Donzel B; Goodman M; Rivier J; Ling N; Vale W
    Nature; 1975 Aug; 256(5520):750-1. PubMed ID: 807858
    [No Abstract]   [Full Text] [Related]  

  • 27. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
    Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
    J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological activities of thionated thyrotropin-releasing hormone analogs.
    Lankiewicz L; Bowers CY; Reynolds GA; Labroo V; Cohen LA; Vonhof S; Sirén AL; Spatola AF
    Biochem Biophys Res Commun; 1992 Apr; 184(1):359-66. PubMed ID: 1314591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The significance of histidines in "thyrotropin-releasing" hormone (TRH)].
    Gillessen D; Piva F; Steiner H; Studer RO
    Helv Chim Acta; 1971; 54(5):1335-42. PubMed ID: 5001098
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyroglutamyl-histidyl-prolineamide (TRH). A neurohormone which affects the release and synthesis of prolactin and thyrotropin.
    Dannies PS; Tashjian AH
    Isr J Med Sci; 1974 Oct; 10(10):1294-304. PubMed ID: 4215776
    [No Abstract]   [Full Text] [Related]  

  • 31. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1.
    Kaur N; Monga V; Lu X; Gershengorn MC; Jain R
    Bioorg Med Chem; 2007 Jan; 15(1):433-43. PubMed ID: 17035026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-Carbobenzoxy-L-pyroglutamyl-L-hitidyl peptides.
    Kurath P; Thomas AM
    Helv Chim Acta; 1973; 56(5):1656-61. PubMed ID: 4200772
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyrotropin secretion in rats after hypothalamic electrical stimulation or injection of synthetic TSH-releasing factor.
    Martin J; Reichlin S
    Science; 1970 Jun; 168(3937):1366-8. PubMed ID: 4986307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of ethanol narcosis by thyrotropin releasing hormone.
    Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA
    Life Sci; 1974 Mar; 14(6):1053-63. PubMed ID: 4207201
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthesis and conformational studies by 1H- and 13C-NMR spectroscopy of a novel, sterically constrained analogue of thyrotropin-releasing hormone.
    Mapelli C; Van Halbeek H; Stammer CH
    Biopolymers; 1990 Feb; 29(2):407-22. PubMed ID: 2158826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbon-13 nuclear magnetic resonance studies on thyrotropin-releasing factor and related peptides.
    Deslauriers R; Garrigou-Lagrange C; Bellocq AM; Smith UC
    FEBS Lett; 1973 Apr; 31(1):59-66. PubMed ID: 4196901
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the inhibition of oxotremorine induced tremor by a melanocyte-stimulating hormone release-inhibiting factor, thyrotropin releasing hormone and related peptides.
    Castensson S; Sievertsson H; Lindeke B; Sum CY
    FEBS Lett; 1974 Aug; 44(1):101-5. PubMed ID: 4212370
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis of thyrotropin-releasing hormone-related peptides using N alpha-tert-butyloxycarbonyl-omega-(N-tert-butyloxycarbonylcarbamoyl)- alpha-amino acids.
    Sakura N; Hirose K; Nishijima M; Hashimoto T; Okabe T; Miyamori C; Sato T
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3125-7. PubMed ID: 2517244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF.
    Burgus R; Dunn TF; Desiderio DM; Ward DN; Vale W; Guillemin R; Felix AM; Gillessen D; Studer RO
    Endocrinology; 1970 Mar; 86(3):573-82. PubMed ID: 4983136
    [No Abstract]   [Full Text] [Related]  

  • 40. An efficient synthesis of thyrotropin releasing hormone (TRH).
    Rivaille P; Milhaud G
    Helv Chim Acta; 1971; 54(1):355-7. PubMed ID: 4993697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.